Switzerland-Austria Bilateral Trade Analysis 2023

Complete trade statistics: $22.02B total volume โ€ขSwitzerland surplus: $238.81M

Switzerland โ†’ Austria

$11.13B

Exports (2023)

Austria โ†’ Switzerland

$10.89B

Imports (2023)

Trade Balance

$238.81M

Surplus for Switzerland

Total Trade

$22.02B

Combined Volume

Trade Flow Visualization

Direct trade relationship between Switzerland and Austria. Green line shows exports from Switzerland, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the Switzerland-Austria commercial relationship and competitive positioning in global markets.

Switzerland โ†’ Austria Exports

$11.13B
2023 Total

Export Market Intelligence

Product Diversity:
Highly Diversified
Market Share:
26.7% top product
1Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts
$2.97B
26.7% of exports
2Metals: gold, semi-manufactured
$956.07M
8.6% of exports
3Metals: gold, non-monetary, unwrought (but not powder)
$664.18M
6.0% of exports
4Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$508.59M
4.6% of exports
5Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$398.87M
3.6% of exports
6Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934
$322.64M
2.9% of exports
7Paintings, drawings and pastels: executed entirely by hand, other than drawings of heading no. 4906
$286.00M
2.6% of exports
8Electrical energy
$280.86M
2.5% of exports
9Metals: silver, unwrought, (but not powder)
$220.95M
2.0% of exports
10Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions
$202.88M
1.8% of exports

๐ŸŽฏ Strategic Export Focus

Switzerland's export portfolio to Austria demonstrates strong diversification across multiple sectors, with polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts representing a key competitive advantage in this bilateral market.

Austria โ†’ Switzerland Imports

$10.89B
2023 Total

Import Dependency Profile

Supply Diversity:
Well Diversified
Critical Imports:
21.7% concentration
1Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale
$2.36B
21.7% of imports
2Electrical energy
$734.41M
6.7% of imports
3Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$361.88M
3.3% of imports
4Metals: gold, non-monetary, unwrought (but not powder)
$188.70M
1.7% of imports
5Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$168.41M
1.5% of imports
6Jewellery: of precious metal (excluding silver) whether or not plated or clad with precious metal, and parts thereof
$135.49M
1.2% of imports
7Iron or steel: structures and parts thereof, n.e.c. in heading 7308
$106.21M
1.0% of imports
8Railway or tramway coaches, vans and trucks: self-propelled, powered from an external source of electricity (excluding those of heading no. 8604)
$105.24M
1.0% of imports
9Wood: builders' joinery and carpentry of wood n.e.c. in heading no. 4418, other than of bamboo
$100.89M
0.9% of imports
10Paper and paperboard: folding cartons, boxes and cases, of non-corrugated paper or paperboard
$83.23M
0.8% of imports

๐Ÿ“ฆ Import Strategy Analysis

Switzerland's import pattern from Austria reveals strategic sourcingin medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale, highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

๐Ÿ†

Market Leadership

Switzerland demonstrates competitive strength in exportingpolypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts to Austria, leveraging comparative advantages.

Export Leader in 20+ Categories
๐Ÿ”„

Trade Complementarity

The bilateral relationship showsstrongcomplementarity, with each country specializing in different sectors.

Highly Balanced
๐Ÿ“ˆ

Growth Potential

The $22.02B trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Major Partnership

Executive Summary: Switzerland-Austria Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $22.02 billionrepresenting a significant bilateral economic relationship
  • Trade Balance: Switzerland maintains a surplus of $238.81 million
  • Export Focus: Switzerland's primary exports include polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts, metals: gold, semi-manufactured, metals: gold, non-monetary, unwrought (but not powder)
  • Import Dependencies: Key imports from Austria include medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale, electrical energy, medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationDiversified
Trade Balance HealthBalanced

๐Ÿ“ˆ Market Position: This bilateral trade relationship represents a significant global trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $22.02B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with Switzerland leveraging its comparative advantages in polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts.

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

Switzerland's specialization in polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its saltscomplements Austria's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale.

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $22.02B bilateral relationship.

Trade Pattern Insights

Trade ComplementarityAsymmetric
Seasonal VariationsModerate
Product ConcentrationLow
Market DependencyModerate
๐Ÿ”ฎ

Trade Relationship Outlook

The $22.02B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

๐Ÿ’ฐ

Trade Volume Impact

The $22.02 billion bilateral trade volume represents a significant economic factorfor both economies.

Economic Significance: High
๐Ÿญ

Industrial Integration

Trade flows in polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts and medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Diversified
โš–๏ธ

Trade Balance Effects

Switzerland's trade surplus of $238.81 million strengthens its overall economic position in this bilateral relationship.

Balance Impact: Well Balanced

Strategic Future Outlook

๐Ÿš€Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in metals: gold, semi-manufactured present expansion opportunities.
Market Diversification
Beyond current focus on medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale, new product categories offer potential for trade expansion.

โš ๏ธRisk Factors

Supply Chain Vulnerabilities
Moderate concentration in key sectors requires monitoring
Market Competition
Global competition in polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts may affect future market positioning.

๐ŸŽฏStrategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between Switzerland and Austria represents a total trade volume of $22.02 billion in 2023. This partnership demonstrates a favorable trade balance for Switzerland, with exports exceeding importsby $238.81 million.

Export Strengths

Switzerland's exports to Austria total $11.13 billion, with competitive advantages in polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts, representing $2.97B or26.7% of bilateral exports.

Import Dependencies

Imports from Austria amount to $10.89 billion, highlighting economic interdependence in medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale, with Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale comprising21.7% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade surplus indicates Switzerland's competitive position in this bilateral relationship. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between Switzerland and Austria in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) โ€ข Last Updated: January 2025 โ€ข Coverage: 1995-2023